pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
Narcolepsy is a debilitating sleep disorder that presents with excessive daytime sleepiness (EDS) and cataplexy, which is a sudden paralysis of muscle tone triggered by strong emotions such as laughing. It is also associated with many other disorders, including psychiatric disorders, neurologic illn...
Saved in:
Main Authors: | Noeen Sarfraz, David Okuampa, Hannah Hansen, Mark Alvarez, Elyse M. Cornett, Juyeon Kakazu, Adam M. Kaye, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-05-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.34222 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Sleepy Medical Student: Exploring Sociodemographic Factors and Excessive Daytime Sleepiness in Iraq
by: Aseel Jasim Ali
Published: (2024-12-01) -
A Practical Approach to Excessive Daytime Sleepiness: A Focused Review
by: Brian J. Murray
Published: (2016-01-01) -
Narcolepsy treatment: from exorcism and bloodletting to modern therapy with histamine receptor inverse agonists
by: E. Sakalauskaitė-Juodeikienė, et al.
Published: (2020-09-01) -
Excessive Daytime Sleepiness among Hypertensive US-Born Blacks and Foreign-Born Blacks: Analysis of the CAATCH Data
by: N. Williams, et al.
Published: (2013-01-01) -
The extent of sleep deprivation and daytime sleepiness in young adults
by: Alexandra Rubin, et al.
Published: (2023-05-01)